Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaloacetate in Parkinson's Disease
NCT01741701Phase 3Completed
- Sponsor
- University of Kansas Medical Center
- Start
- Dec 2012
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxaloacetate in Parkinson's disease (PD), sponsored by University of Kansas Medical Center. Started Dec 2012; status: completed.
02
Drugs
oxaloacetate
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT01741701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01741701.